Evidence map›Paper›PMID 35254525›Full record

ArticleInsights into imaging2022

Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC.

Raffaella Fiamma Cabini, Francesca Brero, Andrea Lancia, Chiara Stelitano, Olga Oneta, Elena Ballante, Emanuela Puppo, Manuel Mariani, Emanuele Alì, Valentina Bartolomeo and 13 more

Registry-linked trialAbstract read
In one paragraph

Article in Insights into imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04364776 (Blue Sky Radiomics), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04364776 unknown statusnot on this map

Blue Sky Radiomics: an Observational Study on Computed Tomography as an Image-based Predictive Marker of Response to Chemoradiation Followed by Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer (NSCLC).

TypeobservationalSponsorFondazione IRCCS Policlinico San Matteo di PaviaRan2020 to 2024Enrolled100ConditionsLung Cancer, Lung Cancer Stage IIIArmsDurvalumab
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Empirical assessment of the assumptions of ComBat with diffusion tensor imaging.Journal of medical imaging (Bellingham, Wash.) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. OptimalFrontiers in oncology · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Raffaella Fiamma CabiniDepartment of Mathematics, Pavia University, Pavia, Italy.
Francesca BreroNational Institute for Nuclear Physics (INFN), Pavia Division, Pavia, Italy.
Andrea LanciaRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Chiara StelitanoRadiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Olga OnetaRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. o.oneta@smatteo.pv.it.
Elena BallanteDepartment of Mathematics, Pavia University, Pavia, Italy.
Emanuela PuppoDepartment of Physics, Pavia University, Pavia, Italy.
Manuel MarianiNational Institute for Nuclear Physics (INFN), Pavia Division, Pavia, Italy.
Emanuele AlìRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Valentina BartolomeoRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Marianna MontesanoRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Elisa MerizzoliRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Diana AluiaRadiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Francesco AgustoniMedical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Giulia Maria StellaDepartment of Clinical Surgical, Diagnostic and Pediatric Sciences, Pavia University, Pavia, Italy.
Roger SunInsititut Gustave Roussy, Villejuif, Paris, France.
Linda BianchiniDepartment of Social and Political Science, Pavia University, Pavia, Italy.
Eric DeutschInsititut Gustave Roussy, Villejuif, Paris, France.
Silvia FiginiDepartment of Social and Political Science, Pavia University, Pavia, Italy.
Chandra BortolottoRadiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Lorenzo PredaRadiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessandro LascialfariNational Institute for Nuclear Physics (INFN), Pavia Division, Pavia, Italy.
Andrea Riccardo FilippiRadiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeIn the retrospective-prospective multi-center "Blue Sky Radiomics" study (NCT04364776), we plan to test a pre-defined radiomic signature in a series of stage III unresectable NSCLC patients undergoing chemoradiotherapy and maintenance immunotherapy. As a necessary preliminary step, we explore the influence of different image-acquisition parameters on radiomic features' reproducibility and apply methods for harmonization. MATERIAL AND

methodsWe identified the primary lung tumor on two computed tomography (CT) series for each patient, acquired before and after chemoradiation with i.v. contrast medium and with different scanners. Tumor segmentation was performed by two oncological imaging specialists (thoracic radiologist and radio-oncologist) using the Oncentra Masterplan® software. We extracted 42 radiomic features from the specific ROIs (LIFEx). To assess the impact of different acquisition parameters on features extraction, we used the Combat tool with nonparametric adjustment and the longitudinal version (LongComBat).

resultsWe defined 14 CT acquisition protocols for the harmonization process. Before harmonization, 76% of the features were significantly influenced by these protocols. After, all extracted features resulted in being independent of the acquisition parameters. In contrast, 5% of the LongComBat harmonized features still depended on acquisition protocols.

conclusionsWe reduced the impact of different CT acquisition protocols on radiomic features extraction in a group of patients enrolled in a radiomic study on stage III NSCLC. The harmonization process appears essential for the quality of radiomic data and for their reproducibility. ClinicalTrials.gov Identifier: NCT04364776, First Posted:April 28, 2020, Actual Study Start Date: April 15, 2020, https://clinicaltrials.gov/ct2/show/NCT04364776 .

Indexed as

ComBatHarmonizationNSCLCRadiomic featuresRobustness

Identifiers

PMID35254525
PMCPMC8901939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.